2-94 (University of South Australia)

N/A

Report date: 2025/01/26 18:30:44
NME

Base Information

Drug Name2-94 (University of South Australia)
Drug Alias NameCDK4 inhibitor (University of South Australia)2-94
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 degraders
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Australia
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of South Australia
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A